Literature DB >> 15814997

Evaluation of PCR testing of ethanol-fixed nasal swab specimens as an augmented surveillance strategy for influenza virus and adenovirus identification.

A E Krafft1, K L Russell, A W Hawksworth, S McCall, M Irvine, L T Daum, J L Connoly, A H Reid, J C Gaydos, J K Taubenberger.   

Abstract

Viral culture isolation has been widely accepted as the "gold standard" for laboratory confirmation of viral infection; however, it requires ultralow temperature specimen storage. Storage of specimens in ethanol at room temperature could expand our ability to conduct active surveillance and retrospective screenings of viruses with rapid and inexpensive real-time PCR tests, including isolates from remote regions where freezing specimens for culture is not feasible. Molecular methods allow for rapid identification of viral pathogens without the need to maintain viability. We hypothesized that ethanol, while inactivating viruses, can preserve DNA and RNA for PCR-based methods. To evaluate the use of ethanol-stored specimens for augmenting surveillance for detection of influenza viruses A and B and adenoviruses (AdV), paired nasal swab specimens were collected from 384 recruits with febrile respiratory illness at Fort Jackson, S.C., in a 2-year study. One swab was stored at ambient temperature in 100% ethanol for up to 6 months, and the other swab was stored at -70 degrees C in viral medium. For viral detection, frozen specimens were cultured for a variety of respiratory viruses, and ethanol-fixed specimens were tested with TaqMan (TM) probe and LightCycler SYBR green (SG) melting curve assays with at least two different PCR targets for each virus. The sensitivities of the TM and SG assays on specimens stored in ethanol for 1 month were 75% and 58% for influenza A, 89% and 67% for influenza B, and 93 to 98% and 57% for AdV, respectively. Lower specificities of the real-time assays corresponded to the increased detection of PCR-positive but culture-negative specimens. Influenza virus RNA was detected as well or better after 6 months of storage in ethanol.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814997      PMCID: PMC1081350          DOI: 10.1128/JCM.43.4.1768-1775.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  The Department of Defense laboratory-based global influenza surveillance system.

Authors:  L C Canas; K Lohman; J A Pavlin; T Endy; D L Singh; P Pandey; M P Shrestha; R M Scott; K L Russell; D Watts; M Hajdamowicz; I Soriano; R W Douce; J Neville; J C Gaydos
Journal:  Mil Med       Date:  2000-07       Impact factor: 1.437

Review 2.  Molecular diagnosis of influenza.

Authors:  Joanna S Ellis; Maria C Zambon
Journal:  Rev Med Virol       Date:  2002 Nov-Dec       Impact factor: 6.989

Review 3.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

4.  Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma.

Authors:  K E Bijwaard; N S Aguilera; Y Monczak; M Trudel; J K Taubenberger; J H Lichy
Journal:  Clin Chem       Date:  2001-02       Impact factor: 8.327

5.  Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples.

Authors:  B Schweiger; I Zadow; R Heckler; H Timm; G Pauli
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

6.  Adenovirus vaccines in the U.S. military.

Authors:  C A Gaydos; J C Gaydos
Journal:  Mil Med       Date:  1995-06       Impact factor: 1.437

7.  Simultaneous detection of influenza viruses A and B using real-time quantitative PCR.

Authors:  L J van Elden; M Nijhuis; P Schipper; R Schuurman; A M van Loon
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

8.  Influenza B virus infections in the community and the family. The epidemics of 1976-1977 and 1979-1980 in Houston, Texas.

Authors:  A L Frank; L H Taber; W P Glezen; E A Geyer; S McIlwain; A Paredes
Journal:  Am J Epidemiol       Date:  1983-09       Impact factor: 4.897

9.  A sensitive, specific, and cost-effective multiplex reverse transcriptase-PCR assay for the detection of seven common respiratory viruses in respiratory samples.

Authors:  Melanie W Syrmis; David M Whiley; Marion Thomas; Ian M Mackay; Jeanette Williamson; David J Siebert; Michael D Nissen; Theo P Sloots
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

10.  Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia.

Authors:  Leontine J R van Elden; Marian G J van Kraaij; Monique Nijhuis; Karin A W Hendriksen; Ad W Dekker; Maja Rozenberg-Arska; Anton M van Loon
Journal:  Clin Infect Dis       Date:  2001-12-04       Impact factor: 9.079

View more
  36 in total

Review 1.  Methods for molecular surveillance of influenza.

Authors:  Ruixue Wang; Jeffery K Taubenberger
Journal:  Expert Rev Anti Infect Ther       Date:  2010-05       Impact factor: 5.091

2.  Design and validation of a universal influenza virus enrichment probe set and its utility in deep sequence analysis of primary cloacal swab surveillance samples of wild birds.

Authors:  Yongli Xiao; Jacqueline M Nolting; Zong-Mei Sheng; Tyler Bristol; Li Qi; Andrew S Bowman; Jeffery K Taubenberger
Journal:  Virology       Date:  2018-09-10       Impact factor: 3.616

3.  Detection of novel (swine origin) H1N1 influenza A virus by quantitative real-time reverse transcription-PCR.

Authors:  Ruixue Wang; Zong-Mei Sheng; Jeffery K Taubenberger
Journal:  J Clin Microbiol       Date:  2009-06-24       Impact factor: 5.948

Review 4.  The relationship between encephalitis lethargica and influenza: a critical analysis.

Authors:  Sherman McCall; Joel A Vilensky; Sid Gilman; Jeffery K Taubenberger
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

5.  Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study.

Authors:  Matthew J Memoli; Lindsay Czajkowski; Susan Reed; Rani Athota; Tyler Bristol; Kathleen Proudfoot; Sarah Fargis; Matthew Stein; Rebecca L Dunfee; Pamela A Shaw; Richard T Davey; Jeffery K Taubenberger
Journal:  Clin Infect Dis       Date:  2014-11-20       Impact factor: 9.079

6.  Genetic analysis of H1N1 influenza virus from throat swab samples in a microfluidic system for point-of-care diagnostics.

Authors:  B Scott Ferguson; Steven F Buchsbaum; Ting-Ting Wu; Kuangwen Hsieh; Yi Xiao; Ren Sun; H Tom Soh
Journal:  J Am Chem Soc       Date:  2011-05-24       Impact factor: 15.419

7.  Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets.

Authors:  Matthew J Memoli; A Sally Davis; Kathleen Proudfoot; Daniel S Chertow; Rachel J Hrabal; Tyler Bristol; Jeffery K Taubenberger
Journal:  J Infect Dis       Date:  2010-12-20       Impact factor: 5.226

8.  Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host.

Authors:  Matthew J Memoli; Rachel J Hrabal; Arash Hassantoufighi; Brett W Jagger; Zong-Mei Sheng; Maryna C Eichelberger; Jeffery K Taubenberger
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

9.  Effects of bacterial microflora of the lower digestive tract of free-range waterfowl on influenza virus activation.

Authors:  Marcus D King; M Neal Guentzel; Bernard P Arulanandam; Adria A Bodour; Vinayak Brahmakshatriya; Blanca Lupiani; James P Chambers
Journal:  Appl Environ Microbiol       Date:  2011-04-29       Impact factor: 4.792

10.  Diagnostic testing for pandemic influenza in Singapore: a novel dual-gene quantitative real-time RT-PCR for the detection of influenza A/H1N1/2009.

Authors:  Hong Kai Lee; Chun Kiat Lee; Tze Ping Loh; Julian Wei-Tze Tang; Lily Chiu; Paul A Tambyah; Sunil K Sethi; Evelyn Siew-Chuan Koay
Journal:  J Mol Diagn       Date:  2010-08-05       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.